Alzheimer's Disease: Abeta

Alzheimer's disease (AD) is a chronic neurodegenerative disease associated with accumulation of amyloid plaques, which are comprised of amyloid beta. Here is the latest research in this field.

July 30, 2020

Beta-amyloid activates NLRP3 inflammasome via TLR4 in mouse microglia

Neuroscience Letters
Yang LiuZuohui Zhang
August 1, 2020

Differences in the free energies between the excited states of Aβ 40 and Aβ 42 monomers encode their aggregation propensities

Proceedings of the National Academy of Sciences of the United States of America
Debayan ChakrabortyD Thirumalai
August 1, 2020
Review

Roflumilast: A potential drug for the treatment of cognitive impairment?

Neuroscience Letters
Lal Jabaris S SuginK Narayan Sunil
August 2, 2020

Association of years to parent's sporadic onset and risk factors with neural integrity and Alzheimer's biomarkers

Neurology
Eider M Arenaza-Urquijo EmALFA study
July 30, 2020
Review
Open Access

Use of Biomarkers in Ongoing Research Protocols on Alzheimer's Disease

Journal of Personalized Medicine
Marco CanevelliNicola Vanacore
July 30, 2020
Open Access

Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders

JAMA : the Journal of the American Medical Association
Sebastian PalmqvistOskar Hansson
July 28, 2020

The Neuropathology of Chronic Traumatic Encephalopathy: The Status of the Literature

Seminars in Neurology
Ann C McKee
July 28, 2020
Review
Open Access

Vesicular Transport of Encapsulated microRNA between Glial and Neuronal Cells

International Journal of Molecular Sciences
Walter J Lukiw, Aileen I Pogue
August 3, 2020

MAM and C99, key players in the pathogenesis of Alzheimer's disease

International Review of Neurobiology
Marta PeraEstela Area-Gomez
July 28, 2020
Open Access

Seeding and Growth of β-Amyloid Aggregates upon Interaction with Neuronal Cell Membranes

International Journal of Molecular Sciences
Álvaro Ruiz-AriasAngel Orte
July 28, 2020
Review

Role of environmental pollutants in Alzheimer's disease: a review

Environmental Science and Pollution Research International
Reyaz Hassan MirMubashir Hussain Masoodi
July 28, 2020
Review
Open Access

Endosomal-Lysosomal Processing of Neurodegeneration-Associated Proteins in Astrocytes

International Journal of Molecular Sciences
Ching-On Wong
August 3, 2020

The impact of neurovascular, blood-brain barrier, and glymphatic dysfunction in neurodegenerative and metabolic diseases

International Review of Neurobiology
Molly Braun, Jeffrey J Iliff
July 27, 2020
Open Access

Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice

Molecular Neurodegeneration
Nicholas F FitzRadosveta Koldamova
July 31, 2020
Open Access

Phosphorylated Aβ peptides in human Down syndrome brain and different Alzheimer's-like mouse models

Acta Neuropathologica Communications
Sathish KumarJochen Walter

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

4H Leukodystrophy

4H Lekodystrophy involves hypomyelination, hypogonadotropic hypogonadism and hypodontia. It is also known as POLR-3Related Leukodystrophy. 4H syndrome symptoms include delayed or abnormal puberty, issues with central nervous system signal transmission, abnormal development of teeth, and symptoms tend to progressively get worse over time. There is not yet a known cure.

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

© 2020 Meta ULC. All rights reserved
/feed-previews/alzheimers-disease-abeta/04a02fd8-ebb8-4fd7-a5af-a23ea43ba447